Inside Health

• Inflammation emerges as a common pathological mechanism across diverse conditions including cancer and neurodegenerative diseases, offering potential for unified therapeutic approaches targeting inflammatory pathways rather than individual diseases.
• Advances in understanding inflammatory biology at the molecular level are enabling development of more targeted anti-inflammatory treatments with improved efficacy and reduced off-target effects compared to conventional broad-spectrum approaches.
• Clinicians should consider inflammatory status as a diagnostic and prognostic marker across multiple specialties, potentially allowing earlier intervention and personalised treatment strategies based on individual inflammatory profiles.

How understanding inflammation could transform treatments from cancer to Alzheimer’s.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.